Star Health Share Price VS Brisk Technovision Share Price Star Health and Allied Insurance has faced challenges since its stock market debut in 2021, with its share price showing a decline due to factors such as high valuations at the time of listing, market volatility, and competitive pressures in the insurance sector. Despite the initial drop, the company has strong fundamentals, backed by a growing demand for health insurance in India. The company’s financial health remains solid. In contrast, Brisk Technovision, which operates in the tech and IT services sector, is expected to see more consistent and steady growth over the next decade. With a current share price of ₹141, the company has made a solid mark in its industry, showing good performance and promising long-term prospects.
Star Health Share Price VS Brisk Technovision Share Price
Star Health and Allied Insurance, one of India’s leading health insurance providers, has shown robust growth since its establishment in 2006. With an expanding footprint in the insurance sector, the company’s share price has been buoyed by increasing demand for health insurance products, especially amidst the growing healthcare needs in India. Given the current trends in the health insurance industry, Star Health’s share price is expected to continue on a positive trajectory in the medium to long term.
On the other hand, Brisk Technovision, with a current share price of INR 141, is looking to raise its visibility through an IPO, despite not raising capital directly from the share sale. The company hopes to increase liquidity for existing shareholders and enhance its market presence. While Brisk Technovision operates in the technology and IT services sector, its growth trajectory is expected to be more volatile compared to the stable and growing health insurance sector. The company’s future share price will be heavily dependent on its ability to scale, secure new contracts, and navigate market conditions.
Star Health Share Price VS Brisk Technovision Share Price Today Prediction
Star Health, despite facing challenges since its market debut in 2021, is showing early signs of recovery with its share price up by 1.22% today. Although the gain is modest, it signals a potential positive trend for the stock over the coming months. Large-cap stocks like Star Health often experience gradual movement, especially in sectors such as health insurance, which require steady growth. Market experts, including Geojit Financial Services, have given a buy recommendation for Star Health, setting a share price target of ₹738, indicating that investors may see more upside if the company can capitalize on increasing health insurance demand and continue improving its financial health.
On the other hand, Brisk Technovision continues to impress with its innovative approach to emerging technologies like Artificial Intelligence, Machine Learning, Cyber Security, and Blockchain. As a rapidly growing tech company, it is well-positioned to benefit from the increasing demand for cutting-edge solutions across industries. Brisk Technovision’s unique value-driven strategy and its commitment to reshaping industry standards are expected to fuel continued growth. The company’s stock is projected to rise consistently, with price targets reaching ₹253 in 2024, ₹262.20 in 2025, and ₹394.50 by 2030.
Star Health Share Price Target 2024 To 2030
Year | Maximum Target (₹) | Minimum Target (₹) |
2024 | 650.56 | 500.07 |
2025 | 761.00 | 553.08 |
2026 | 874.01 | 557.15 |
2027 | 988.44 | |
2028 | 1,109.47 | 663.20 |
2029 | 1,223.44 | 720.66 |
2030 | 1,335.10 | 773.69 |
Star Health Share Price Target 2024, 2025, 2026, 2027, 2028, 2029 To 2030
Star Health Share Price Target 2024 500.07, 2025 553.08, 2026 557.15, 2027 602.34, 2028 663.20, 2029 720.66, To 2030 773.69. Full Information
Brisk Technovision Share Price Target 2024 To 2030
Brisk Technovision Share Price Target | |
Brisk Technovision Share Price Target 2024 | |
Brisk Technovision Share Price Target 2025 | |
Brisk Technovision Share Price Target 2026 | |
Brisk Technovision Share Price Target 2027 | |
Brisk Technovision Share Price Target 2028 | |
Brisk Technovision Share Price Target 2029 | |
Brisk Technovision Share Price Target 2030 | |
Brisk Technovision Share Price Target 2024, 2025, 2026, 2027, 2028, 2029 To 2030
Brisk Technovision’s projected share prices are: 2024 ₹253.00, 2025 ₹262.20, 2026 ₹280.40, 2027 ₹297.20, 2028 ₹321.70, and reaching ₹394.50 by 2030. Full Information
Star Health Share Price Outlook (2024–2030)
Star Health and Allied Insurance, despite initial challenges since its market debut in 2021, shows signs of gradual recovery. While its share price has fluctuated, the company remains well-positioned within the fast-growing Indian health insurance sector. Analysts suggest that the stock could continue its upward momentum, with a target price of ₹738 for 2024, driven by increasing health insurance penetration and the expanding need for healthcare services in India. By 2025, the share price could rise to ₹850–1,000, with further growth potential reaching ₹1,200–1,400 by 2026. By 2030, Star Health could see its stock price range from ₹1,800 to ₹2,200, assuming steady growth in the health insurance sector and effective management of regulatory challenges.
Brisk Technovision Share Price Outlook (2024–2030)
Brisk Technovision, a company specializing in cutting-edge technologies such as Artificial Intelligence, Machine Learning, Cyber Security, and Blockchain, is poised for strong growth. The company has a clear focus on innovation and expanding its footprint in these high-demand sectors. Investors can expect the stock price to grow steadily, with targets of ₹253 in 2024, ₹262.20 in 2025, and ₹280.40 in 2026. By 2030, the stock price could potentially reach ₹394.50, reflecting the ongoing digital transformation and technological advancements that Brisk Technovision is capitalizing on. Compared to Star Health, Brisk Technovision’s performance is more dependent on the tech industry’s rapid growth, offering high potential returns in a short to medium-term horizon.
Summary Comparison (2024-2030)
While both companies offer growth potential, Star Health is expected to see steady, long-term growth driven by the healthcare sector’s expansion, particularly in India’s insurance market. The stock is projected to rise moderately from ₹738 in 2024 to around ₹1,800–2,200 by 2030. In contrast, Brisk Technovision is anticipated to grow at a faster pace due to its involvement in emerging tech sectors, with its stock likely to rise from ₹253 in 2024 to ₹394.50 by 2030, offering a more aggressive growth trajectory. For long-term investors, Brisk Technovision may present higher returns, while Star Health offers a more stable, steady investment within the healthcare and insurance domain.